IO Biotech, Inc.IOBTNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank95
3Y CAGR+64.9%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
+64.9%/yr
Quarterly compound
Percentile
P95
Near historical high
vs 3Y Ago
4.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 68.04% |
| Q2 2025 | -16.93% |
| Q1 2025 | 28.44% |
| Q4 2024 | -30.47% |
| Q3 2024 | -16.09% |
| Q2 2024 | -6.32% |
| Q1 2024 | 25.69% |
| Q4 2023 | -20.77% |
| Q3 2023 | -2.37% |
| Q2 2023 | -24.25% |
| Q1 2023 | 15.08% |
| Q4 2022 | -27.94% |
| Q3 2022 | 15.18% |
| Q2 2022 | -7.50% |
| Q1 2022 | 19.26% |
| Q4 2021 | -377.57% |
| Q3 2021 | 88.37% |
| Q2 2021 | -923.45% |
| Q1 2021 | -46.75% |
| Q4 2020 | 26.78% |
| Q3 2020 | -16.27% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |